Craig Bryan, PsyD, ABPP
banner
craigjbryan.bsky.social
Craig Bryan, PsyD, ABPP
@craigjbryan.bsky.social
clinical psychologist | suicide & PTSD researcher | Air Force veteran | author | speaker | The Ohio State University | all views my own
I’ve been surprised by how often I’m asked to run new analyses from clinical trials that include variables or groupings that were not originally reported. Aside from the time commitment involved in that, it seems problematic to include findings from new and otherwise unreported analyses.
April 6, 2025 at 7:01 PM
I estimate that I receive 4-6 requests per year now related to meta-analyses that ask for some sort of reanalysis. I’m okay with simple things like “hey can you tell us what the r value is for men separate from women in this one study you did?”
April 6, 2025 at 6:56 PM
I can think of many instances where the information provided in a meta analysis cannot be traced back to the original publication. How often are “ghost findings” included in meta-analyses?
April 6, 2025 at 6:49 PM
A question I’ve wondered about this: if the original study can only meet inclusion criteria by running analyses that were not previously conducted or don’t flow naturally from the original study aims, is it appropriate to include in a meta-analysis?
April 6, 2025 at 6:46 PM
We used the Stanley-Brown form.
December 28, 2023 at 10:51 PM
CRP’s advantage held at 6 and 12 months although this advantage was not statistically significant. CRP also had around 50% fewer suicide attempts than safety planning.

Overall results support the superiority of CRP vs safety planning. This is the second RCT to support CRP’s effectiveness.
December 28, 2023 at 10:35 PM
The latter. The rationale is that the big gains have already been made so the effect sizes going forward will be much smaller by default. I think it reflects a bias that views larger effect sizes as more impactful.
December 8, 2023 at 11:07 PM
I should note that I’m making this point not only as someone proposing tx refinements but also as a fellow reviewer who has rebutted this perspective more than once.
December 8, 2023 at 3:46 AM
The rationale presented is often that the treatment is already better than something else with a much larger effect size, so any refinements by default will have smaller effect sizes, which is viewed as having low impact.
December 8, 2023 at 3:43 AM
This issue is especially pronounced in suicide prevention. I’m stunned by how often reviewers discount efforts to make an effective tx even more effective. It’s akin to saying “20% of patients attempting suicide in tx is okay. Trying to reduce that to 10% isn’t meaningful.”
December 8, 2023 at 3:32 AM
Me: okay, here you go.

University: rejected. The amount charged doesn’t match our calculations of exchange rates.

Me: 🤷🏻‍♂️ that’s what I paid.

University: we’re only going to reimburse you 99.999% of your voucher total.

Me: Ok…. So you spent hundreds of dollars to save <$10. Cool cool cool.
November 16, 2023 at 2:26 AM
It’s been a few years since that happened to me. I do wonder how that happens.
November 1, 2023 at 1:09 AM
Did anyone by chance give you a sock?
November 1, 2023 at 1:00 AM